GSA Capital Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
196,607
+170,680
| +658% | +$293K | 0.02% | 1185 |
|
|
2025
Q1 | $86K | Buy |
+25,927
| New | +$86K | 0.01% | 1517 |
|
|
2024
Q4 | – | Sell |
-25,824
| Closed | -$242K | – | 1803 |
|
|
2024
Q3 | $242K | Buy |
+25,824
| New | +$242K | 0.02% | 1334 |
|
|
2024
Q2 | – | Sell |
-61,225
| Closed | -$907K | – | 1825 |
|
|
2024
Q1 | $907K | Buy |
+61,225
| New | +$907K | 0.07% | 502 |
|
|
2023
Q2 | – | Sell |
-216,782
| Closed | -$1.33M | – | 1716 |
|
|
2023
Q1 | $1.33M | Buy |
216,782
+40,989
| +23% | +$251K | 0.13% | 188 |
|
|
2022
Q4 | $1.12M | Buy |
175,793
+95,017
| +118% | +$607K | 0.14% | 165 |
|
|
2022
Q3 | $774K | Sell |
80,776
-97,802
| -55% | -$937K | 0.1% | 284 |
|
|
2022
Q2 | $1.97M | Buy |
178,578
+161,755
| +962% | +$1.79M | 0.3% | 13 |
|
|
2022
Q1 | $280K | Buy |
16,823
+1,425
| +9% | +$23.7K | 0.04% | 944 |
|
|
2021
Q4 | $294K | Buy |
+15,398
| New | +$294K | 0.04% | 946 |
|
|
2021
Q1 | – | Sell |
-5,321
| Closed | -$247K | – | 1282 |
|
|
2020
Q4 | $247K | Buy |
+5,321
| New | +$247K | 0.04% | 853 |
|
|
2019
Q2 | – | Sell |
-14,266
| Closed | -$136K | – | 1572 |
|
|
2019
Q1 | $136K | Sell |
14,266
-12,734
| -47% | -$121K | 0.01% | 1298 |
|
|
2018
Q4 | $239K | Buy |
+27,000
| New | +$239K | 0.03% | 989 |
|